Nuwellis, Inc. (NUWE | DoD: +1.83% | YTD: -80.48% | SmallCap: 4M)

• Profile: A medical technology company focused on fluid management solutions for patients with fluid overload
• Stock Offering: Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option (Full Text)

BrainsWay Ltd. (BWAY | DoD: +4.09% | YTD: +19.62% | SmallCap: 193M)

• Profile: A global leader in advanced noninvasive neurostimulation treatments for mental health disorders
• Clinical: BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD) (Full Text)

Helius Medical Technologies, Inc. (HSDT | DoD: -2.31% | YTD: -91.98% | SmallCap: 2M)

• Profile: A neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits
• Regulatory: Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device (Full Text)

Johnson & Johnson (JNJ | DoD: +0.79% | YTD: +10.43% | LargeCap: 373.9B)

• Profile: Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide
• Clinical: New data show TREMFYA® (guselkumab) is the only IL-23 inhibitor proven to significantly inhibit progression of joint structural damage in active psoriatic arthritis (Full Text)

Femasys Inc. (FEMY | DoD: -0.01% | YTD: -27.28% | SmallCap: 22M)

• Profile: A leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products
• Partnership: Femasys Announces Partnership with Carolinas Fertility Institute, One of America's Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations (Full Text)

IQVIA Holdings Inc. (IQV | DoD: +3.65% | YTD: -18.12% | MidCap: 24.4B)

• Profile: Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries
• Product: IQVIA Launches New AI Agents for Life Sciences and Healthcare (Full Text)

Inspira Technologies Oxy B.H.N. Ltd. (IINN | DoD: -3.81% | YTD: -33.12% | SmallCap: 16M)

• Profile: A specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure
• Product: Inspira's ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions (Full Text)

Intelligent Bio Solutions Inc. (INBS | DoD: +7.35% | YTD: +29.43% | SmallCap: 10M)

• Profile: A medical technology company, developing rapid, non-invasive testing, and screening solutions
• Product: Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing (Full Text)

MaxCyte, Inc. (MXCT | DoD: +5.96% | YTD: -44.34% | SmallCap: 238M)

• Profile: A life sciences company, discovers, develops, and commercializes cell therapeutics
• Collaboration: MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies (Full Text)

NanoVibronix, Inc. (NAOV | DoD: -8.27% | YTD: -88.07% | SmallCap: 3M)

• Profile: Focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance
• Patent: ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System (Full Text)

Castle Biosciences, Inc. (CSTL | DoD: -0.72% | YTD: -35.66% | SmallCap: 468M)

• Profile: A company improving health through innovative tests that guide patient care
• Event: Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention (Full Text)

Illumina, Inc. (ILMN | DoD: +3.53% | YTD: -32.80% | MidCap: 12.9B)

• Profile: Provides sequencing- and array-based solutions for genetic and genomic analysis
• Report: lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics (Full Text)

Teleflex Incorporated (TFX | DoD: +1.76% | YTD: -29.58% | MidCap: 5.4B)

• Profile: A provider of specialty medical devices for a range of procedures in critical care and surgery
• Announcement: Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month (Full Text)

Hyperfine, Inc. (HYPR | DoD: +3.24% | YTD: -18.44% | SmallCap: 64M)

• Profile: A health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system
• Leadership Update: Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI (Full Text)

Johnson & Johnson (JNJ | DoD: +0.79% | YTD: +10.43% | LargeCap: 373.9B)

• Profile: Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide
• Leadership Update: Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors (Full Text)

bioAffinity Technologies, Inc. (BIAF | DoD: +3.84% | YTD: -68.32% | SmallCap: 7M)

• Profile: Engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis
• Leadership Update: bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas' Leadership Board (Full Text)